Skip to content
Unrated Drug recall · FDA · Published October 6, 2026

Amlodipine and Olmesartan Medoxomil Tablets

Out of specification due to dissolution.

🇺🇸 FDA recall #D-0045-2027DrugAscend Laboratories, LLC ›
Write-up in progress

We’re still writing up this recall

We break every recall down into plain English — this one’s still on our list. Until our write-up is ready, the official FDA hazard and remedy below have the full, accurate details.

Source Page by GovInfoNow · govinfonow.com/recall/1927666-ascend-laboratories-llc-recalls-amlodipine-and-olmesartan-medoxomil-tablets-10mg · Recall date October 6, 2026 · FDA enforcement record: FDA #D-0045-2027

Cite this page

“Amlodipine and Olmesartan Medoxomil Tablets.” GovInfoNow, recall dated October 6, 2026. https://govinfonow.com/recall/1927666-ascend-laboratories-llc-recalls-amlodipine-and-olmesartan-medoxomil-tablets-10mg. Based on FDA recall #D-0045-2027 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0045-2027%22&limit=1).

How to tell if you have this one

  • Brand
    Ascend Laboratories, LLC
  • Category
    Drug

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 22 days after the firm started it.

1. Firm started the recall: Oct 6, 202612. FDA classified it Class II: Oct 16, 202623. Published in FDA’s Enforcement Report: Oct 28, 202634. Added to GovInfoNow: Nov 3, 202642026
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. Added to GovInfoNow

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Ascend Laboratories, LLC recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0045-2027 (October 6, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0045-2027 to see it in context.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA